How many units / tirzepatide
How Many Units Is 2.5 mg of Tirzepatide?
For 2.5 mg of tirzepatide, divide the dose by the strength on the label (mg per mL), then multiply by 100 for units on a U-100 insulin syringe. The single-dose vial is 5 mg/mL, which gives 50 units. The multi-dose vial is 4.17 mg/mL, which gives 60 units for its 0.6 mL dose. This is math for those vial types. It isn’t a recommendation to use a compounded product. Check whether the label says single-dose or multi-dose before you compare unit numbers.
Last updated
| Measure | Single-dose vial5 mg/mL0.5 mL per dose | Multi-dose vial4.17 mg/mL0.6 mL per dose (2.4 mL holds 4 doses) |
|---|---|---|
| Liquid per dose | 0.5 mL | 0.6 mL |
| Units on a U-100 insulin syringe | 50 units | 60 units |
| On a 1 mL syringe | right on a line | right on a line |
A U-40 or other syringe would give a different draw for this 2.5 mg Tirzepatide example.
This page answers the 2.5 mg Tirzepatide example; use the strength printed on your label.
Already drew some? Check it with the units to mg calculator, opened at this page's 2.5 mg tirzepatide example.
Your numbers
Syringe size and line spacing
The syringe's barrel or packaging says 0.3 mL, 0.5 mL or 1 mL (or 30, 50 or 100 units).
DosePep · dosing card
Tirzepatide
These are example numbers. Change them to match your vial and prescription.
Vial strength: 5 mg/mL
Dose: 2.5 mg
50 units
0.50 mL
Example drawing of a U-100 syringe, not to size. It shows where the result falls on this scale; it is not an injection instruction.
A smaller syringe (0.5 mL (50 units)) holds this dose and is easier to read.
| Dose | Units | mL | Syringe |
|---|---|---|---|
| 2.5 mg | 50 units | 0.50 mL | 1.0 mL syringe |
| 5 mg | 100 units | 1.00 mL | 1.0 mL syringe |
| 7.5 mg | 150 units | 1.50 mL | more than 1 mL |
| 10 mg | 200 units | 2.00 mL | more than 1 mL |
| 12.5 mg | 250 units | 2.50 mL | more than 1 mL |
| 15 mg | 300 units | 3.00 mL | more than 1 mL |
These doses come from the FDA labels. Your prescriber decides which dose you take and when.
This is math only, not medical advice. Follow your prescriber's and pharmacist's instructions.
Made with DosePep at https://dosepep.com
Where 2.5 mg fits on the label
On the Mounjaro and Zepbound labels, 2.5 mg a week is the starting dose for four weeks. The Zepbound label says it’s only for starting, not a dose to stay on. This is the only label step described as a starting dose.
Brand-name products with this dose
Brand-name products that give 2.5 mg include:
- Mounjaro: 2.5 mg / 0.5 mL (single-dose pen)
- Mounjaro: 2.5 mg / 0.5 mL (single-dose vial)
- Mounjaro: 10 mg / 2.4 mL (multi-dose vial)
- Mounjaro: 10 mg / 2.4 mL (KwikPen)
- Zepbound: 2.5 mg / 0.5 mL (single-dose pen)
- Zepbound: 2.5 mg / 0.5 mL (single-dose vial)
- Zepbound: 10 mg / 2.4 mL (multi-dose vial)
- Zepbound: 10 mg / 2.4 mL (KwikPen)
Questions about 2.5 mg
Is this page recommending 2.5 mg?
No. It only turns a prescribed 2.5 mg dose into units at a given strength. Your prescriber and the product label decide whether that amount is right for you.
Is tirzepatide approved?
Yes. Tirzepatide is sold as FDA-approved brand-name products. But this page doesn’t choose a product, dose or form for you.
How many units is 2.5 mg at the single-dose vial strength (5 mg/mL)?
At 5 mg/mL, 2.5 mg is 50 units on a U-100 insulin syringe. Whether that can be read exactly depends on the lines printed on the syringe.
Which syringe sizes fit 2.5 mg in this example?
In this example, the liquid for 2.5 mg fits in these syringes: 0.5 mL (50 units), 1.0 mL (100 units). This is not instructions for any product.
Related guides
The basics behind this answer, then the calculator for your own vial.
Sources
The medical and device facts on this page come from these sources. Each entry shows the date we accessed it.
- 01 Mounjaro (tirzepatide) US Prescribing Information · Eli Lilly, 08/2026. Accessed 2026-09-28.
- 02 Zepbound (tirzepatide) US Prescribing Information · Eli Lilly, 08/2026. Accessed 2026-09-28.
- 03 Zepbound single-dose vial Instructions for Use · Eli Lilly, 04/2026. Accessed 2026-09-28.
- 04 Zepbound full US labeling · Eli Lilly, 08/2026. Accessed 2026-10-01.
- 05 Technical Data Sheet – Insulin Syringes · embecta, Rev B, 12/2025. Accessed 2026-09-28.
- 06 Injection technique guide · embecta, ©2025, EMB-05148. Accessed 2026-09-28.
- 07 Getting Started booklet · embecta, ©2023. Accessed 2026-09-28.
- 08 SafetyGlide Insulin Syringes quick reference guide · embecta. Accessed 2026-09-28.
- 09 ISO 8537:2016, sterile single-use insulin syringes · International Organization for Standardization, 2016. Accessed 2026-09-28.
- 10 FDA's concerns with unapproved GLP-1 drugs used for weight loss · U.S. Food and Drug Administration, 10/01/2026. Accessed 2026-10-01.
- 11 FDA clarifies policies for compounders as GLP-1 supply stabilizes · U.S. Food and Drug Administration, 04/01/2026. Accessed 2026-09-28.
Medically reviewed by Ashley Alexis, NDLast reviewed How we review